Eva Csinady

Minimal Residual Disease Values Discriminate Between Low and High Relapse Risk in Children With B-Cell Precursor Acute Lymphoblastic Leukemia and an Intrachromosomal Amplification of Chromosome 21: The Austrian and German Acute Lymphoblastic Leukemia Berlin-Frankfurt-Münster (ALL-BFM) Trials

Andishe Attarbaschi, Georg Mann, Renate Panzer‐Grümayer et al. · Journal of Clinical Oncology · 2008 · 111 citations · Full text

R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes

John F. Seymour, M Pfreundschuh, Marek Trněný et al. · Haematologica · 2014 · 106 citations · Full text

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect

D.M. Chen, Adefowope Odueyungbo, Eva Csinady et al. · British Journal of Dermatology · 2019 · 91 citations · Full text

Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The ‘big sister’ of the infant disease?

Georg Mann, Giovanni Cazzaniga, Vincent H. J. van der Velden et al. · Leukemia · 2007 · 26 citations · Full text

Hematological Malignancy, Hematology, Pediatrics +6

Chromosome 14 copy number-dependent IGH gene rearrangement patterns in high hyperdiploid childhood B-cell precursor ALL: implications for leukemia biology and minimal residual disease analysis

Eva Csinady, Vincent H. J. van der Velden, Ruth Joas et al. · Leukemia · 2009 · 11 citations

Hematological Malignancy, Chromatin, Cytogenetics +8